Replies to post #268709 on Elite Pharmaceuticals Inc (ELTP)

[FALCON1]

Could you elaborate more on the series J convertible shares? please TIA

[lasers]

What needs to be understood by shareholders is that SunGen on Jul 28, 2017 gave $ELTP a new contract with 4 additional drugs to R&D and then file with the FDA ASAP. This new contract, also pays $ELTP cost plus to develop and manufacture when FDA approval is given. On July 12, 2017 SunGen had given a new contract for the development of 5 drugs

http://ir.elitepharma.com/profiles/investor/ResLibraryView.asp?ResLibraryID=83792&BzID=2258&g=939&Nav=0&LangID=1&s=0

http://ir.elitepharma.com/profiles/investor/ResLibraryView.asp?ResLibraryID=83724&GoTopage=1&Category=2163&BzID=2258&t=2086&G=939

There is only one way that a savvy partner such as SunGen would have quickly added 4 more drugs to the 5 drug, a mere 16 days later, is that $ELTP is confident that the FDA will now officially clear the new SOPS for adverse events allowing new drugs approvals. $ELTP is waiting for the official FDA letter which should be arriving anyday now.